Missing ligand for donor iKIR: higher aGVHD3−4 and TRM (AML);  Missing HLA-C2 for donor KIR2DL1: higher aGVHD2/3−4 (AML). This evidence concerns the gene KIR2DL1 and acute myeloid leukemia.